Previous Article | Next Article 
Clinical and Diagnostic Laboratory Immunology, January 2000, p. 21-24, Vol. 7, No. 1
1071-412X/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Species-Specific Monoclonal Antibodies for Rapid
Identification of Bartonella quintana
Zhongxing
Liang and
Didier
Raoult*
Unité des Rickettsies, CNRS UPRES-A
6020, Faculté de Médecine, Université de la
Mediterranée, Marseille, France
Received 27 May 1999/Returned for modification 20 July
1999/Accepted 27 September 1999
 |
ABSTRACT |
Seven species-specific monoclonal antibodies (MAbs) to
Bartonella quintana were produced and characterized. The
MAbs were of the immunoglobulin G class and reacted only with 13 B. quintana strains in indirect microimmunofluorescence and
Western immunoblotting assays. They did not react with eight other
Bartonella spp., including Bartonella henselae,
the most closely related species, and a selected MAb did also not react
with nine other strains of gram-negative bacteria. The MAbs reacted
mainly with a 34-kDa protein epitope of B. quintana which
was shown to be species specific by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis. Four of five body lice
experimentally infected with B. quintana were found to be
positive for the organism in microimmunofluorescence assays with one
MAb. These MAbs may provide a specific, simple, rapid, and low-cost
tool for the identification of B. quintana and the diagnosis of infections due to the microorganism.
 |
INTRODUCTION |
Bartonella spp. are
gram-negative, short-rod bacteria. Presently there are 14 recognized
species within the genus Bartonella (2, 3, 9, 11,
12), and of these, four species are currently recognized as human
pathogens: B. bacilliformis, B. quintana,
B. henselae, and B. elizabethae (6).
B. bacilliformis was the earliest species of this genus to
be described (23) and is the agent of Carrion's disease.
Infections with B. bacilliformis have yet to be reported
from outside a very restricted geographic region in the Andes of
western South America. B. quintana was first recognized
during World War I as the etiological agent of trench fever. Although
Vinson and Fuller (28) isolated the organism in 1961, there
was little scientific interest in the organism or trench fever for the
next 20 years, as they were apparently only very rarely encountered.
Recent investigations, however, have led to the reemergence of B. quintana as an organism of medical importance. Bacillary
angiomatosis was initially characterized by the appearance of multiple
cutaneous lesions, which were assumed to be infectious because these
lesions contained bacilli that stained with Warthin-Starry stain
(1, 5, 16) and resolved with antibiotic treatment
(5). Subsequently the observed bacillus was characterized by
PCR and 16S rRNA gene sequencing, which showed it to be a new organism
closely related to B. quintana (22), and in 1992 B. quintana was isolated from skin lesions of bacillary angiomatosis patients (14). The organism has also been found to be associated with other, less specific clinical syndromes, such as
bacteremia (26), endocarditis (7, 19, 27),
chronic lymphadenopathy (20), neurological disorders
(29), and chronic bacteremia in homeless patients
(4). There is a need, then, for rapid and specific methods
to identify B. quintana and differentiate it from other
Bartonella species. In this report we describe the characteristics and specificities of seven species-specific monoclonal antibodies (MAbs) that we produced against B. quintana.
 |
MATERIAL AND METHODS |
Bartonella strains.
The sources of the
Bartonella strains used in the study are listed in Table
1. Bartonella isolates were
grown on Columbia blood agar containing 5% whole sheep blood
(BioMerieux, Marcy l'Etoile, France) at 37°C with a 5% carbon
dioxide atmosphere, except for B. bacilliformis, which was
grown at 32°C. After 5 to 7 days of culture, the organisms were
harvested and suspended in sterile deionized water for sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) or with
phosphate-buffered saline (pH 6.8) (PBS) for microimmunofluorescence
(MIF).
Production of MAbs.
For production of MAbs (10),
6-week-old female BALB/c mice were inoculated three times
intraperitoneally with 2 × 104 B. quintana
Fuller organisms, suspended in 0.5 ml of PBS, at 7-day intervals. One
week after the final intraperitoneal inoculation the mice were injected
intravenously with 4 × 103 organisms suspension in
0.1 ml of PBS. Three days later, spleen cells from the mice were fused
with SP2/0-Ag14 myeloma cells (10:1) by using 50% polyethylene glycol
(molecular weight, 1,300 to 1,600; Sigma Chemical Co., St. Louis, Mo.).
Fusion cells were grown in hybridoma medium (Seromed, Berlin, Germany)
with 17% fetal bovine serum (Gibco BRL) and
hypoxanthine-aminopterin-thymidine selective medium (Sigma Chemical
Co.) at 37°C in a humidified atmosphere supplemented with 5%
CO2. The supernatants were screened for antibodies to
B. quintana by MIF, and positive hybridomas were subcloned twice by limiting dilution. Isotypes of MAbs were determined with an
ImmunoType Mouse Monoclonal Antibody Isotyping Kit with antisera to
mouse immunoglobulin M (IgM), IgA, IgG1, IgG2a, IgG2b, and IgG3 (Sigma
Chemical Co.). Specificities of MAbs were tested by Western immunoblotting.
MIF assay.
The MIF assay (18) was used to screen
hybridoma clones and to determine the specificities of MAbs. Antigens
were placed on 24-well microscope slides with a pen nib. The antigens
were fixed in methanol for 10 min at room temperature and incubated in
a humidified chamber at 37°C for 30 min. After two washes in PBS (5 min each) and rinsing in sterile distilled water, the slides were air
dried at 37°C. Following incubation at 37°C for 30 min with
dechlorotriazinyl amino fluorescein-conjugated goat anti-mouse IgG plus
IgM (Jackson ImmunoResearch Laboratories, Inc., West Grove, Pa.)
diluted 1:200 in PBS with 0.2% Evans blue (BioMerieux), the slides
were washed as described above and mounted with Fluoprep (BioMerieux)
before being read under an epifluorescence microscope (Axioskop20; Carl
Zeiss, Gottingen, Germany) at a magnification of ×400. Sera from
immunized mice were used as positive controls, and sera from healthy
unexposed mice were used as negative controls.
SDS-PAGE and Western immunoblotting.
Antigens were suspended
in an equal volume of sample buffer (0.0625 M Tris hydrochloride [pH
8.0], 2% SDS, 5% 2-mercaptoethanol, 10% glycerol, 0.02%
bromophenol blue) (15) and separated electrophoretically in
12% resolving gels with 5% stacking gels at a constant current of 8 to 10 mA per gel for 3 to 4 h in running buffer (25 mM Tris, 192 mM glycine, 0.1% SDS) in a Mini Protein II apparatus (Bio-Rad, Richmond, Calif.). Prestained SDS-PAGE standards (low range; Bio-Rad) were used as a reference. The separated antigens were transferred to
0.45-µm-pore-size nitrocellulose membranes (Hybond-C; Amersham, Little Chalfont, United Kingdom) at 50 V for 1 h at 4°C in an electrophoretic transfer cell (Mini Trans-Blot; Bio-Rad). After transfer, the nitrocellulose membranes were incubated overnight in PBS
with 5% nonfat dry milk to block nonspecific binding sites. After
three 10-min washes in PBS, the membranes were air dried and cut into
strips, which were incubated with MAbs diluted 1:10 in PBS containing
3% nonfat dry milk at room temperature for 1 h and washed as
described above. After incubation at room temperature for 1 h with
peroxidase-conjugated F(ab')2 fragment goat anti-mouse IgG
(heavy and light chains) (AffiniPure; Jackson ImmunoResearch) diluted
1:200 in PBS with 3% nonfat dry milk and three washes in PBS, color
was developed with coloring buffer containing 0.015% 4-chloro-1-naphthol and 0.015% hydrogen peroxide in 16.7% methanol in
Tris-buffered saline.
Blind testing of bacteria with MAbs.
Blind testing of 26 bacteria by MIF with MAb Bq73H4 was carried out with 13 B. quintana strains isolated from patients in Marseille, France, by
our laboratory; 5 Bartonella strains of other species; and
Escherichia coli, Desulfovibrio fairfieldensis, Enterococcus faecalis, Afipia clevelandensis,
Pseudomonas aeruginosa, Stenotrophomonas
maltophila, Afipia felis, and Klebsiella
pneumoniae.
Detection of Bartonella in lice preparations.
Twenty milliliters of a suspension of 1010 B. quintana Oklahoma organisms per ml was injected intravenously into
a New Zealand White rabbit over 30 min. Following the injection, five
human body lice were applied to the previously shaved belly of the
rabbit and allowed to feed for 15 min. After being crushed and smeared onto microscope slides, these body lice were tested for B. quintana by MIF with undiluted hybridoma Bq73H4 supernatant as
described above.
 |
RESULTS |
MIF reactivities and isotypes of MAbs.
Seven MAbs of
subclasses IgG3, IgG1, and IgG2a (Table
2) produced from subcloned hybridomas
were examined for their reactivities with Bartonella
strains. These MAbs were reactive at identical titers with all B. quintana strains tested, except strain URBQPIEH2 (Table 2), and
did not react at all with the other Bartonella species
tested.
SDS-PAGE.
Although the SDS-PAGE profiles of the different
species of Bartonella differed (Fig.
1), a 34-kDa protein appeared to be
specific for B. quintana, and this was also the most
prominent band in the SDS-PAGE profiles.

View larger version (87K):
[in this window]
[in a new window]
|
FIG. 1.
Coomassie brilliant blue staining profiles of
Bartonella strains on SDS-PAGE. Lanes: 1, B. bacilliformis; 2, B. henselae subspecies
houstoniae; 3, B. henselae subspecies
massiliae; 4, B. clarridgeiae; 5, B. quintana; 6, B. elizabethae; 7, B. grahamii;
8, B. taylorii; 9, B. doshiae; 10, B. vinsonii. Molecular mass markers were loaded on the left.
|
|
Western immunoblotting.
The seven MAbs reacted with a 34-kDa
epitope of all B. quintana strains but did not react with
any antigens of the other Bartonella species (Fig.
2). In Western blots of B. quintana antigens that had been digested with proteinase K, the
MAbs failed to react with the 34-kDa epitope. Heating of the antigens
(100°C for 10 min) before immunoblotting did not, however, affect the
reactivities of the MAbs (Fig. 3).

View larger version (53K):
[in this window]
[in a new window]
|
FIG. 2.
Western immunoblotting of MAb Bq100G5 with
Bartonella antigens. Lanes: 1, B. quintana
Fuller; 2, B. quintana URBQMLY4; 3, B. quintana
Oklahoma; 4, B. quintana URBQPIEH2; 5, B. quintana SH-perm; 6, B. quintana URBQTBAAH1; 7, B. quintana URBQMTF17; 8, B. quintana URBQMTF12;
9, B. quintana URBQMLYI5; 10, B. quintana
URBQPBAA7; 11, B. quintana URBQLIEH6; 12, B. quintana URBQMTF14; 13, B. quintana URBQMTF15; 14, B. bacilliformis Monzon 812; 15, B. henselae
Hounton-1; 16, B. henselae URBHLLY 8; 17, B. elizabethae; 18, B. grahamii V2; 19, B. taylorii M6; 20, B. doshiae R18; 21, B. vinsonii Baker; 22, B. clarridgeiae. Molecular mass
markers were loaded on the left.
|
|

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 3.
Immunoblotting of B. quintana Fuller antigens
treated with MAbs in different ways. Lanes N, native antigens without
treatment; lanes P, antigens treated with proteinase K (Boehringer,
Mannheim, Germany) at 1.5 mg/ml at 37°C for 1.5 h; lanes H,
antigens heated at 100°C for 5 min. MAbs: group 1, Bq73H4; group 2, Bq85G7; group 3, Bq86D12; group 4, Bq90H6; group 5, Bq99C9; group 6, Bq100E9; group 7, Bq100G5. Molecular mass markers were loaded on the
left.
|
|
Blind testing of bacteria with MAbs.
The supernatant from
hybridoma Bq73H4 reacted with all of the strains of B. quintana tested but did not react with the other Bartonella species or with the other bacteria used in the study.
Detection of B. quintana in lice.
Bartonella
could be demonstrated in four of the five infected lice by MIF with
MAbs Bq73H4 (Fig. 4), Bq85G7, and
Bq100E9.

View larger version (109K):
[in this window]
[in a new window]
|
FIG. 4.
Fluorescent antibody-stained organisms of B. quintana on a crushed infected-lice smear with supernatant of
undiluted hybridoma Bq73H4.
|
|
 |
DISCUSSION |
Several methods for confirming the identification of presumptive
Bartonella spp. have been described, ranging from the
comparison of the biochemical reactivities of isolates to more complex
genotypic and phenotypic analyses. While Bartonella spp.
were once considered to be relative inert, our laboratory
(8) found that the introduction of 100 µg of hemin per ml
to the test media resulted in the bacteria giving positive reactions in
a number of biochemical tests. This then enabled the effective
differentiation of B. quintana, B. henselae, and
B. vinsonii from one another. The differentiation of
Bartonella spp. has also been shown to be possible by using an extensive range of genotypic analyses, and DNA-DNA hybridization has
clearly demonstrated the taxonomic position of Bartonella spp. (3, 6, 21). The 16S rRNA gene sequences of
Bartonella spp. have been shown to be similar but unique for
each species (3, 6, 17, 21), and Bartonella spp.
can be differentiated by restriction fragment length polymorphism
analyses of amplified 16S rRNA gene products with a combination of
DdeI and MnlI (2). Similarly,
PCR-restriction fragment length polymorphism analysis of the citrate
synthase gene enables the identification of Bartonella spp.
(13, 17), which can also be differentiated by pulsed-field gel electrophoresis with various restriction enzymes (17).
Only a few phenotypic characteristics have been reported for the
identification of Bartonella at the species level (17, 25). In our experiments, we were able to produce and characterize species-specific MAbs to B. quintana. All seven of our MAbs
reacted with various antigens of B. quintana in MIF and
Western immunoblotting assays. The MAb (Bq73H4) selected for diagnostic
purpose did not react with antigens of other Bartonella
species as determined with eight strains of other bacteria, which
clearly indicates that it is species specific for B. quintana. We note that the reactivity of our MAbs with B. quintana isolate URBQPIEH2 was relatively weak. This indicates
that there might be antigenic differences between strains of B. quintana, and further research to resolve this issue is under way
in our laboratory.
The MAbs that we describe in this report appear, then, to be suitable
for use in rapid, simple, accurate, and low-cost tests such as direct
and indirect MIF assays to differentiate Bartonella spp. The
use of the MAbs would appear to be particularly useful in
differentiating B. quintana and B. henselae,
organisms which cause similar clinical signs in patients and have to
date been differentiated only by using more expensive and complicated
genotypic analyses. The MAbs could also be of use in epidemiological
studies, as we were able to use MAbs Bq73H4, Bq85G7, and Bq100E9 to
detect B. quintana by MIF in four of the five lice that we
experimentally infected with the organism, and could be complementary
with PCR detection (24).
 |
ACKNOWLEDGMENTS |
We thank Armand Tasmadjian for assistance with the experiments,
P. E. Fournier for assistance with the photography, and P. Kelly
for reviewing the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Unité des
Rickettsies, CNRS UPRES-A 6020, Faculté de Médecine, 27 Blvd. Jean Moulin, 13385 Marseille Cedex 5, France. Phone: (33) 4 91 83 43 75. Fax: (33) 4 91 83 03 90. E-mail:
Didier.Raoult{at}medecine.univ-mrs.fr.
 |
REFERENCES |
| 1.
|
Angritt, P.,
S. M. Tuur,
A. M. Macher,
K. J. Smith,
C. S. Park,
F. P. Hobin, and C. Myrie-Williams.
1988.
Epithelioid angiomatosis in HIV infection: neoplasm or cat-scratch disease.
Lancet
i:996.
|
| 2.
|
Birtles, R. J.,
T. G. Harrison,
N. A. Saunders, and D. H. Molyneux.
1995.
Proposals to unify the genera Grahamella and Bartonella, with descriptions of Bartonella talpae comb. nov., Bartonella peromysci comb. nov., and three new species, Bartonella grahamii sp. nov., Bartonella taytorii sp. nov., and Bartonella doshiae sp. nov.
Int. J. Syst. Bacteriol.
45:1-8[Abstract/Free Full Text].
|
| 3.
|
Brenner, D. J.,
S. P. O'Connor,
H. H. Winkler, and A. G. Steigerwalt.
1993.
Proposals to unify the genera Bartonella and Rochalimaea, with descriptions of Bartonella quintana comb. nov., Bartonella vinsonii comb. nov., Bartonella henselae comb. nov., and Bartonella elizabethae comb. nov., and to remove the family Bartonellaceae from the order Rickettsiales.
Int. J. Syst. Bacteriol.
43:777-786[Abstract/Free Full Text].
|
| 4.
|
Brouqui, P.,
B. Lascola,
V. Roux, and D. Raoult.
1999.
Chronic Bartonella quintana bacteremia in homeless patients.
N. Engl. J. Med.
340:184-189[Abstract/Free Full Text].
|
| 5.
|
Cockerell, C. J.,
G. F. Webster,
M. A. Whitlow, and A. E. Friedman-Kien.
1987.
Epithelioid angiomatosis: a distinct vascular disorder in patients with the acquired immunodeficiency syndrome or AIDS-related complex.
Lancet
ii:654-656[CrossRef].
|
| 6.
|
Daly, J. S.,
M. G. Worthington,
D. J. Brenner,
C. M. Moss,
D. G. Hollis,
R. S. Weyant,
A. G. Steigerwalt,
R. E. Weaver,
M. I. Daneshvar, and S. P. O'Connor.
1993.
Rochalimaea elizabethae sp. nov. isolated from a patient with endocarditis.
J. Clin. Microbiol.
31:872-881[Abstract/Free Full Text].
|
| 7.
|
Drancourt, M.,
J. L. Mainardi,
P. Brouqui,
F. Vandenesch,
A. Carta,
F. Lehnert,
J. Etienne,
F. Goldstein,
J. Acar, and D. Raoult.
1995.
Bartonella (Rochalimaea) quintana endocarditis in three homeless men.
N. Engl. J. Med.
332:419-423[Abstract/Free Full Text].
|
| 8.
|
Drancourt, M., and D. Raoult.
1993.
Proposed tests for the routine identification of Rochalimaea species.
Eur. J. Clin. Microbiol. Infect. Dis.
12:710-713[CrossRef][Medline].
|
| 9.
|
Droz, S.,
B. Chi,
E. Horn,
A. G. Steigerwalt,
A. M. Whitney, and D. J. Brenner.
1999.
Bartonella koehlerae sp. nov., isolated from cats.
J. Clin. Microbiol.
37:1117-1122[Abstract/Free Full Text].
|
| 10.
|
Harlow, E., and D. Lane.
1988.
Monoclonal antibodies and growing hybridomas, p. 139-282.
In
E. Harlow, and D. Lane (ed.), Antibodies: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 11.
|
Heller, R.,
P. Riegel,
Y. Hansmann,
G. Delacour,
D. Bermond,
C. Dehio,
F. Lamarque,
H. Monteil,
B. Chomel, and Y. Piemont.
1998.
Bartonella tribocorum sp. nov., a new Bartonella species isolated from the blood of wild rats.
Int. J. Syst. Bacteriol.
48:1333-1339[Abstract/Free Full Text].
|
| 12.
|
Heller, R.,
M. Kubina,
P. Mariet,
P. Riegel,
G. Delacour,
C. Dehio,
F. Lamarque,
R. Kasten,
H. J. Boulouis,
H. Monteil,
B. Chomel, and Y. Piemont.
1999.
Bartonella alsatica sp. nov., a new Bartonella species isolated from the blood of wild rabbits.
Int. J. Syst. Bacteriol.
49:283-288[Abstract/Free Full Text].
|
| 13.
|
Joblet, C.,
V. Roux,
M. Drancourt,
J. Gouvernet, and D. Raoult.
1995.
Identification of Bartonella (Rochalimaea) species among fastidious gram-negative bacteria on the basis of the partial sequence of the citrate-synthase gene.
J. Clin. Microbiol.
33:1879-1883[Abstract].
|
| 14.
|
Koehler, J. E.,
F. D. Quinn,
T. G. Berger,
P. E. LeBoit, and J. W. Tappero.
1992.
Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis.
N. Engl. J. Med.
327:1625-1631[Abstract].
|
| 15.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature (London).
227:680-685[CrossRef][Medline].
|
| 16.
|
LeBiot, P. E.,
T. G. Berger,
B. M. Egbert,
Y. S. B. Yen,
M. H. Stoler, and T. A. Bonfiglio.
1988.
Epithelioid hemangioma-like vascular proliferation in AIDS: manifestations of cat scratch disease bacillus infection.
Lancet
i:960-963.
|
| 17.
|
Maurin, M.,
V. Roux,
A. Stein,
F. Ferrier,
R. Viraben, and D. Raoult.
1994.
Isolation and characterization by immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, Western blot, restriction fragment length polymorphism-PCR, 16S rRNA gene sequencing, and pulsed-field gel electrophoresis of Rochalimaea quintana from a patient with bacillary angiomatosis.
J. Clin. Microbiol.
32:1166-1171[Abstract/Free Full Text].
|
| 18.
|
Philip, R. N.,
E. A. Casper,
W. Burgdorfer,
R. K. Gerloff,
L. B. Hughes, and E. J. Bell.
1978.
Serologic typing of Rickettsiae of the spotted fever group by microimmunofluorescence.
J. Immunol.
121:1961-1968[Abstract/Free Full Text].
|
| 19.
|
Raoult, D.,
P. E. Fournier,
M. Drancourt,
T. J. Marrie,
J. Etienne,
J. Cosserat,
P. Cacoub,
Y. Poinsignon,
P. Leclercq, and A. M. Sefton.
1996.
Diagnosis of 22 new cases of Bartonella endocarditis.
Ann. Intern. Med.
125:646-652[Abstract/Free Full Text].
|
| 20.
|
Raoult, D.,
M. Drancourt,
A. Carta, and J. A. Gastaut.
1994.
Bartonella (Rochalimaea) quintana isolation in patient with chronic adenopathy, lymphopenia, and a cat.
Lancet
343:977[CrossRef][Medline].
|
| 21.
|
Regnery, R. L.,
B. E. Anderson,
J. E. Clarridge,
M. C. Rodriguez-Barradas,
D. C. Jones, and J. H. Carr.
1992.
Characterization of a novel Rochalimaea species, R. henselae sp. nov., isolated from blood of a febrile, human immunodeficiency virus-positive patient.
J. Clin. Microbiol.
30:265-274[Abstract/Free Full Text].
|
| 22.
|
Relman, D. A.,
J. S. Loutit,
T. M. Schmith,
S. Falkow, and L. S. Tompkins.
1990.
The agent of bacillary angiomatosis. An approach to the identification of uncultured pathogens.
N. Engl. J. Med.
323:1573-1580[Abstract].
|
| 23.
|
Ristic, R., and J. P. Kreier.
1984.
Family II. Bartonellaceae, p. 717-719.
In
N. R. Krieg, and J. G. Holt (ed.), Bergey's manual of systematic bacteriology, vol. 1. The Williams & Wilkins Co., Baltimore, Md.
|
| 24.
|
Roux, V., and D. Raoult.
1999.
Body lice as tools for diagnosis and surveillance of reemerging diseases.
J. Clin. Microbiol.
37:596-599[Abstract/Free Full Text].
|
| 25.
|
Slater, L. N.,
D. W. Coody,
L. K. Woolridge, and D. F. Welch.
1992.
Maurine antibody responses distinguish Rochalimaea henselae from Rochalimaea quintana.
J. Clin. Microbiol.
30:1722-1727[Abstract/Free Full Text].
|
| 26.
|
Spach, D. H.,
A. S. Kanter,
M. J. Dougherty,
A. M. Larson,
M. B. Coyle,
D. J. Brenner,
B. Swaminathan,
G. M. Matar,
D. F. Welch,
R. K. Root, and W. E. Stamm.
1995.
Bartonella (Rochalimaea) quintana bacteremia in inner-city patients with chronic alcoholism.
N. Engl. J. Med.
332:424-428[Abstract/Free Full Text].
|
| 27.
|
Spach, D. H.,
K. P. Callis,
D. S. Paauw,
Y. B. Houze,
F. D. Schoenknecht,
D. F. Welch,
H. Rosen, and D. J. Brenner.
1993.
Endocarditis caused by Rochalimaea quintana in a patient infected with human immunodeficiency virus.
J. Clin. Microbiol.
31:692-694[Abstract/Free Full Text].
|
| 28.
|
Vinson, J. W., and H. S. Fuller.
1961.
Studies on trench fever. 1. Propagation of Rickettsia-like organisms from a patient's blood.
Pathol. Microbiol.
24:S152-S166.
|
| 29.
|
Wong, M. T.,
M. J. Dolan,
C. P. Lattuada, Jr.,
R. L. Regnery,
M. L. Garcia,
E. C. Mokulis,
R. C. LaBarre,
D. P. Ascher,
J. A. Delmar,
J. W. Kelly,
D. R. Leigh,
A. C. McRae,
J. B. Reed,
R. E. Smith, and G. P. Melcher.
1995.
Neuroretinitis, aseptic meningitis, and lymphadenitis associated with Bartonella (Rochalimaea) henselae infection in immunocompetent patients and patients infected with human immunodeficiency virus type 1.
Clin. Infect. Dis.
21:352-360[Medline].
|
Clinical and Diagnostic Laboratory Immunology, January 2000, p. 21-24, Vol. 7, No. 1
1071-412X/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Inokuma, H., Brouqui, P., Dumler, J. S., Raoult, D.
(2003). Serotyping Isolates of Anaplasma phagocytophilum by Using Monoclonal Antibodies. CVI
10: 969-972
[Abstract]
[Full Text]
-
Gilmore, R. D. Jr., Carpio, A. M., Kosoy, M. Y., Gage, K. L.
(2003). Molecular Characterization of the sucB Gene Encoding the Immunogenic Dihydrolipoamide Succinyltransferase Protein of Bartonella vinsonii subsp. berkhoffii and Bartonella quintana. Infect. Immun.
71: 4818-4822
[Abstract]
[Full Text]
-
Yamamoto, K., Chomel, B. B., Kasten, R. W., Hew, C. M., Weber, D. K., Lee, W. I., Droz, S., Koehler, J. E.
(2002). Experimental Infection of Domestic Cats with Bartonella koehlerae and Comparison of Protein and DNA Profiles with Those of Other Bartonella Species Infecting Felines. J. Clin. Microbiol.
40: 466-474
[Abstract]
[Full Text]
-
Liang, Z., La Scola, B., Raoult, D.
(2002). Monoclonal Antibodies to Immunodominant Epitope of Tropheryma whipplei. CVI
9: 156-159
[Abstract]
[Full Text]
-
Liang, Z., La Scola, B., Lepidi, H., Raoult, D.
(2001). Production of Bartonella Genus-Specific Monoclonal Antibodies. CVI
8: 847-849
[Abstract]
[Full Text]